Semaglutide, the active ingredient in the diabetes and weight-loss drugs Ozempic and Wegovy, appears to slow biological aging in humans, according to new clinical research. Scientists observed slower progression of aging markers in adults with HIV who took the medication, providing the first human evidence that the drug may influence the aging process itself.
The research team measured epigenetic clocks, which track changes in DNA methylation patterns that correlate with cellular aging. Participants receiving semaglutide showed reduced advancement of these biological age markers compared to controls, suggesting the drug slowed aging at the molecular level.
This discovery connects to semaglutide's known effects on metabolism and inflammation. The medication helps regulate blood sugar and reduces appetite by activating GLP-1 receptors, which also influence inflammatory pathways and cellular stress responses. Both inflammation and cellular damage drive aging, so semaglutide's anti-inflammatory properties may underpin the observed slowdown in aging markers.
The study carries important limitations. Researchers conducted the work in a population with HIV, whose aging patterns differ from the general population. Sample sizes remain small, and longer follow-up periods are needed to determine whether slowed biological aging translates to extended lifespan or improved health outcomes. The mechanisms behind semaglutide's effects on aging clocks require further investigation.
The findings feed growing interest in repurposing existing drugs for lifespan extension. Earlier animal studies hinted that GLP-1 receptor agonists might influence aging, but human clinical evidence remained absent until now. Establishing whether semaglutide genuinely extends human lifespan or delays age-related diseases demands large-scale, long-term trials in diverse populations.
Millions take semaglutide globally for weight loss and diabetes management, creating a unique opportunity to gather aging data from existing patients. Researchers emphasize that